Dyax Corp Profile

38.41
null 0.00  0.00%
38.41Trading Day  High 38.41 

Selected Dyax Corp Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Key Fundamentals

Dyax Corp Against Markets

Dyax Corporation, a biopharmaceutical company, identifies, develops, and commercializes treatments for hereditary angioedema and other plasmakallikreinmediated disorders. more
Fama & French Business Services
Business Services
Fama & French Classification
NameDyax Corp
Analyst Consensus
Macroaxis Advice
InstrumentUSA Stock Stocks Directory
LocationMASSACHUSETTS, U.S.A
Business AddressBurlington, MA
ExchangeNASDAQ General Markets
CUSIP26746E103
IndustryBusiness Services
BenchmarkDOW
Websitewww.dyax.com
Contact Number617 225 2500
Currencynull

Recommendations

Dyax Corp Analyst Recommendations
Target PriceAdvice# of Analysts
34.72Hold6Odds
Dyax Corp current and past analyst recommendations published by number of research institutions as well as average analyst consensus
Dyax Corp Analyst Advice  

Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas